Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.63
-0.07 (-1.23%)
Sep 2, 2026, 1:09 PM EDT - Market open
Taysha Gene Therapies Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 14, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $19 | Buy | Maintains | $19 | +237.48% | Aug 12, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $13 | Buy | Maintains | $13 | +130.91% | Aug 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $17 | Buy | Maintains | $17 | +201.95% | Aug 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 | Buy | Maintains | $12 | +113.14% | Aug 12, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Buy Reiterates $11 | Buy | Reiterates | $11 | +95.38% | Aug 12, 2026 |
| Needham | Needham | Buy Maintains $12 | Buy | Maintains | $12 | +113.14% | Aug 12, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $14 | Buy | Maintains | $14 | +148.67% | Jul 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.